Literature DB >> 15322817

[Chemotherapy-induced changes in high grade central osteosarcomas-experiences gained through the assignment as reference-pathologists of the COSS-studies].

M Werner1, G Delling.   

Abstract

High-grade central osteosarcomas are the most frequent malignant bone neoplasms in childhood and adolescence. Their prognosis has been substantially improved using neoadjuvant chemotherapy. The morphological examination of surgical specimens reveals important information regarding the success of treatment. The histological determined degree of regression represents one of the most reliable therapy-related prognostical factor. Thus pathological analysis of the surgical specimens is of great importance notwithstanding the improved clinical and radiological diagnostic of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322817     DOI: 10.1007/s00292-004-0712-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  26 in total

Review 1.  Musculoskeletal tumor staging: 1988 update.

Authors:  W F Enneking
Journal:  Cancer Treat Res       Date:  1989

2.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

3.  Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Authors:  K Winkler; G Beron; G Delling; U Heise; H Kabisch; C Purfürst; J Berger; J Ritter; H Jürgens; V Gerein
Journal:  J Clin Oncol       Date:  1988-02       Impact factor: 44.544

4.  Multidrug resistance and malignancy in human osteosarcoma.

Authors:  K Scotlandi; M Serra; G Nicoletti; M Vaccari; M C Manara; G Nini; L Landuzzi; A Colacci; G Bacci; F Bertoni; P Picci; M Campanacci; N Baldini
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

5.  MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.

Authors:  J S Wunder; S B Bull; V Aneliunas; P D Lee; A M Davis; C P Beauchamp; E U Conrad; R J Grimer; J H Healey; M J Rock; R S Bell; I L Andrulis
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

6.  [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].

Authors:  S Bielack; B Kempf-Bielack; D Schwenzer; T Birkfellner; G Delling; V Ewerbeck; G U Exner; N Fuchs; U Göbel; N Graf; U Heise; K Helmke; A R von Hochstetter; H Jürgens; R Maas; N Münchow; M Salzer-Kuntschik; J Treuner; U Veltmann; M Werner; W Winkelmann; A Zoubek; R Kotz
Journal:  Klin Padiatr       Date:  1999 Jul-Aug       Impact factor: 1.349

7.  Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80.

Authors:  M Salzer-Kuntschik; G Delling; G Beron; R Sigmund
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

8.  Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.

Authors:  N Fuchs; S S Bielack; D Epler; P Bieling; G Delling; D Körholz; N Graf; U Heise; H Jürgens; R Kotz; M Salzer-Kuntschik; P Weinel; M Werner; K Winkler
Journal:  Ann Oncol       Date:  1998-08       Impact factor: 32.976

9.  Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience.

Authors:  D B Glasser; J M Lane; A G Huvos; R C Marcove; G Rosen
Journal:  Cancer       Date:  1992-02-01       Impact factor: 6.860

Review 10.  Prognostic factors in osteosarcoma: a critical review.

Authors:  A M Davis; R S Bell; P J Goodwin
Journal:  J Clin Oncol       Date:  1994-02       Impact factor: 44.544

View more
  2 in total

Review 1.  [Musculoskeletal tumors: significance of morphological diagnostics].

Authors:  M Werner; K Hauptmann; C H Lohmann; G Jundt
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

Review 2.  [Osteogenic tumors of bone].

Authors:  B Jobke; M Werner
Journal:  Radiologe       Date:  2016-06       Impact factor: 0.635

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.